AI Prescription Renewals: Innovation Meets Safety Concerns

Doctronic's AI system has become the first to gain state approval for autonomously renewing prescriptions. However, a security test exposed vulnerabilities, raising alarms about patient safety. Critics worry that the Utah regulatory sandbox prioritizes innovation over necessary oversight. Physician groups argue that removing human checks risks patient health. The FDA's role in ensuring safety remains unaddressed. As the pilot continues, the focus is on producing reliable evidence for this groundbreaking approach.